201327 - Boostrix® Pregnancy Registry: a prospective, exploratory, cohort study to detect and describe any abnormal pregnancy outcomes in women intentionally or unintentionally vaccinated with Boostrix® during pregnancy or within 28 days preceding conception

25/03/2014
16/04/2024
EU PAS number:
EUPAS6086
Study
Finalised
Documents
Study protocol
Initial protocol
English (312.35 KB - PDF) View document
Updated protocol
English (1.62 MB - PDF) View document
Study results
Study results
English (550.99 KB - PDF) View document
Study report
Other information
Publications